B W Cooper - JoVE Visualize

Showing results (21-30 of 41) with videos related to

Pageof 5

Sort By:

Journal of Neuro-Oncology|March 1, 1996

Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patientsH I Tahsildar, B F Remler, R J Creger, et al.

The British Journal of Dermatology|April 1, 1994

An inflammatory eruption associated with recombinant human IL-6T E Fleming, W S Mirando, L F Soohoo, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapyO N Koç, S L Gerson, B W Cooper, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1996

Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisD P Nicolau, M N Marangos, C H Nightingale, et al.

International Journal of Antimicrobial Agents|July 1, 1996

Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patientsH M Lazarus, R J Creger, R Gucalp, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000

Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factorD P Schenkein, Y Koc, T Alcindor, et al.

Bone Marrow Transplantation|June 1, 1995

Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancerH M Lazarus, E F Winton, S F Williams, et al.

Blood|October 1, 1994

Sequential administration of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a phase I/II multicenter studyJ W Fay, H Lazarus, R Herzig, et al.

Seminars in Oncology|August 1, 1993

Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignanciesP Crilley, H Lazarus, D Topolsky, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.

Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:

Pageof 5

Journal of Neuro-Oncology|March 1, 1996

Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patientsH I Tahsildar, B F Remler, R J Creger, et al.

The British Journal of Dermatology|April 1, 1994

An inflammatory eruption associated with recombinant human IL-6T E Fleming, W S Mirando, L F Soohoo, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapyO N Koç, S L Gerson, B W Cooper, et al.

Antimicrobial Agents and Chemotherapy|January 1, 1996

Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisD P Nicolau, M N Marangos, C H Nightingale, et al.

International Journal of Antimicrobial Agents|July 1, 1996

Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patientsH M Lazarus, R J Creger, R Gucalp, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000

Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factorD P Schenkein, Y Koc, T Alcindor, et al.

Bone Marrow Transplantation|June 1, 1995

Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancerH M Lazarus, E F Winton, S F Williams, et al.

Blood|October 1, 1994

Sequential administration of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a phase I/II multicenter studyJ W Fay, H Lazarus, R Herzig, et al.

Seminars in Oncology|August 1, 1993

Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignanciesP Crilley, H Lazarus, D Topolsky, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.

Pageof 5